United States · FDA National Drug Code directory
Chlorothiazide Sodium
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 0517-1820_2c97dd4f-150c-4fc0-9400-2d8305bb21b0
- Product NDC
- 0517-1820
- Form
- INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
- Composition / generic term
- Chlorothiazide Sodium
- Labeler
- American Regent, Inc.
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20150401
- Source listing expiry
- 20261231
Source-listed ingredients
- CHLOROTHIAZIDE SODIUM — 500 mg/18mL
These values do not establish equivalence or a dose recommendation.
Packages
- 1 VIAL in 1 CARTON (0517-1820-01) / 18 mL in 1 VIAL · 0517-1820-01
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →